Saturated fat and cardiovascular disease controversy
||This article is written like a personal reflection or opinion essay that states the Wikipedia editor's particular feelings about a topic, rather than the opinions of experts. (November 2014)|
Whether saturated fat is a risk factor for cardiovascular disease (CVD) is a question with numerous controversial views. Although most in the mainstream heart-health, government, and medical communities hold that saturated fat is a risk factor for CVD, some hold contrary beliefs.
Medical, scientific, heart-health, governmental and intergovernmental, and professional authorities, such as the World Health Organization, the American Dietetic Association, the Dietitians of Canada, the British Dietetic Association, American Heart Association, the British Heart Foundation, the World Heart Federation, the British National Health Service, the United States Food and Drug Administration, and the European Food Safety Authority advise that saturated fat is a risk factor for cardiovascular disease (CVD), and recommend dietary limits on saturated fats as one means of reducing that risk.
- 1 History
- 2 Systematic reviews
- 3 Views
- 3.1 Mainstream authorities
- 3.2 Editorial, commentary and conference findings in medical journals
- 3.3 Conflicting views
- 3.4 Industry groups
- 4 See also
- 5 Further reading
- 6 References
Cholesterol and cardiovascular disease
The initial connection between arteriosclerosis and cholesterol was made by the Russian pathologist Nikolay Anichkov. Another significant contribution to the debate was made by the Dutch physician (internist) Cornelis de Langen who noticed the correlation between nutritional cholesterol intake and incidence of gallstones (and soon after arteriosclerosis and other "Western diseases") in Javanese population in 1916. De Langen reported on his findings at the conference of the International Society of Geographic Pathology in 1935. This observation was made on patients admitted to the municipal hospital in Jakarta. Consequently, he studied this phenomenon in defined populations outside the hospital. He showed that the traditional Javanese diet, very poor in cholesterol and other lipids, was associated with low level of blood cholesterol as well as incidence of the cardiovascular disease, while the prevalence of CVD in Europeans in Java, living on the Western diet, was significantly higher. De Langen's colleague Isidor Snapper made a similar observation in North China in 1940. Since de Langen published his results only in Dutch, his work remained unknown to most of the international scientific community.
Saturated fat and cardiovascular disease
The notion that saturated fat has a detrimental effect on human health gained attention for the first time in the 1950's. It was promoted by Ancel Keys, a US nutritional scientist. Keys postulated a correlation between cholesterol levels and cardiovascular disease and initiated a study of Minnesota businessmen (the first prospective study of CVD). At a 1955 expert meeting of the World Health Organization in Geneva, Keys presented his diet-lipid-heart disease hypothesis. At that time in the USA, the heart disease was on steep rise, with no apparent cause. Keys reaped severe criticism at the conference. Consequently, he set out to develop the yearslong Seven Countries Study.
|Systematic review||Relationship between cardiovascular disease and saturated fatty acids (SFA)|
|de Souza, 2015||"Saturated fats are not associated with all cause mortality, CVD, CHD, ischemic stroke, or type 2 diabetes, but the evidence is heterogeneous with methodological limitations."|
|Schwab, 2014||"there was convincing evidence that partial replacement of SFA with PUFA [polyunsaturated fat] decreases the risk of CVD, especially in men."|
|Chowdhury, 2014||"Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats.".|
|Hooper, 2011||Reducing saturated fat in diets reduced the risk of having a cardiovascular event by 14 percent (no reduction in mortality).|
|Mozaffarian, 2010||19% reduction in Coronary Heart Disease (CHD) events by replacing saturated fatty acids (SFA) with polyunsaturated fatty acids (PUFA). (Note: the study included n-3 fatty acids in the PUFA group).|
|Siri-Tarino, 2010||No significant evidence for concluding that dietary saturated fat is associated with an increased risk of CHD or CVD.|
|Danaei, 2009||Intervention studies replacing SFA with PUFA showed an insignificant relative risk (1.01-1.04) for ischemic heart disease (IHD).|
|Mente, 2009||"The evidence supports a valid association of a limited number of dietary factors and dietary patterns with CHD."|
|Skeaff, 2009||Reduced events by substituting PUFA|
|Jakobsen, 2009||5% SFA replaced with PUFA: 13% decrease in events, 26% decrease in deaths|
|Van Horn, 2008||25-35% fats but <7% SFA and TFA reduces risk.|
|Chanu, 2003||Significant in longer term.|
|Hu, 1999||Eating nuts in place of SFA gave 45% reduction.|
|Truswell, 1994||Decrease SFA and cholesterol intake, partial replacement with PUFA: 6% reduced deaths, 13% reduced events|
In 2014, a systematic review and meta-analysis in the Annals of Internal Medicine, by Dr. Rajiv Chowdhury et al., of 72 published studies totaling 530,525 participants, looked at observational studies of dietary intake of fatty acids, observational studies of measured fatty acid levels in the blood, and intervention studies of polyunsaturated fat supplementation. The authors of the review concluded that, ″Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats.″
However, Walter Willett, chair of the Department of Nutrition at Harvard School of Public Health, warns that the conclusions are seriously misleading, as the analysis contains major errors and omissions and should be retracted. In response to the Chowdhury review, Drs. Willett, Frank Sacks, and Meir Stampfer commented that:
- ″The meta-analysis of dietary fatty acids and risk of coronary heart disease by Chowdhury et al. contains multiple errors and omissions, and the conclusions are seriously misleading, particularly the lack of association with N-6 polyunsaturated fat. For example, two of the six studies included in the analysis of N-6 polyunsaturated fat were wrong. The relative risks for Nurses’ Health Study (NHS) and Kuopio Ischemic Heart Disease Study (KIHD) were retrieved incorrectly and said to be above 1.0. However, in the 20-year follow-up of the NHS the relative risk for highest vs lowest quintile was 0.77 (95 percent CI: 0.62, 0.95); ptrend = 0.01 (the authors seem to have used the RR for N-3 alpha-linolenic acid from a paper on sudden cardiac death), and in the KIHD the relative risk was 0.39; 95% confidence interval [CI], 0.21-0.71) (the origin of the number used in the meta-analysis is unclear). Also, relevant data from other studies were not included.
- Further, the authors did not mention a pooled analysis of the primary data from prospective studies, in which a significant inverse association between intake of polyunsaturated fat (the large majority being the N-6 linoleic acid) and risk of CHD was found. Also, in this analysis, substitution of polyunsaturated fat for saturated fat was associated with lower risk of CHD. Chowdhury et al. also failed to point out that most of the monounsaturated fat consumed in their studies was from red meat and dairy sources, and the findings do not necessarily apply to consumption in the form of nuts, olive oil, and other plant sources. Thus, the conclusions of Chowdhury et al. regarding the type of fat being unimportant are seriously misleading and should be disregarded.″
In a 2013 systematic review in the American Journal of Cardiovascular Disease, Fred Kummerow relays information about the role of oxidized LDL and the role of saturated and poly-unsaturated fats role in the formation of atherosclerosis. He shows two studies where polyunsaturated fats are the main contributor to atherosclerosis and coronary heart disease.
A 2011 systematic review from The Cochrane Library analyzed 48 studies conducted between 1965 and 2009 and included 65,508 participants. All studies reduced or modified participants’ dietary fat or cholesterol for at least six months by at least 30 percent. It was found that reducing saturated fat by reducing and/or modifying dietary fat reduced the risk of having a cardiovascular event, such as heart attack, stroke and unplanned heart surgery, by 14 percent. Of the 65,508 participants, 7 percent had a cardiovascular event.
"The findings are suggestive of a small but potentially important reduction in cardiovascular risk on modification of dietary fat, but not reduction of total fat, in longer trials. Lifestyle advice to all those at risk of cardiovascular disease and to lower risk population groups, should continue to include permanent reduction of dietary saturated fat and partial replacement by unsaturates. The ideal type of unsaturated fat is unclear". In a summary it goes on to say "there are no clear health benefits of replacing saturated fats with starchy foods".
A 2010 systematic review and meta-analysis of randomized controlled trials commissioned by the National Heart, Lung, and Blood Institute found that consuming polyunsaturated fat in place of saturated fat led to a 19% reduction in Coronary Heart Disease.
In 2010, a meta-analysis of prospective cohort studies supported by the National Dairy Council including 348,000 subjects found no statistically significant relationship between cardiovascular disease and dietary saturated fat. This study has been criticized for not using unadjusted data from the cohort studies, potentially biasing in the direction of the study's conclusion. One of the authors of this study received funding from Unilever, a producer of margarine, ice cream, and mayonnaise products. Another author of this study received funding from the National Cattlemen's Beef Association.
In a subordinate meta-analysis to a 2009 risk assessment supported by the Centers for Disease Control and Prevention (CDC), an ischemic heart disease mortality residual risk of 1.05 was determined for the 30-44 year age group for each 1% isocaloric reduction in PUFA in favour of SFA. Higher age groups had lower residual risks.
In 2009, a systematic review supported by the Heart and Stroke Foundation of Canada of prospective cohort studies or randomized trials concluded that there was "insufficient evidence of association" between intake of saturated fatty acids and coronary heart disease, and pointed to strong evidence for protective factors such as vegetables and a Mediterranean diet and harmful factors such as trans fats and foods with a high glycemic index.
A 2009 meta-analysis supported by the NHBLI focused on the effects of trans-fats also applied the same techniques to studies focused on SFA, MUFA and PUFA, in order to assess the relative risk of substituting trans-fats with other fats. Risks were assessed from two classes of data - risk factors in trials, and disease outcomes in cohort studies. In order of decreasing risk, the fat types were TFA, SFA, MUFA and PUFA. From the trials analysis, it was found that for partially hydrogenated vegetable oil with 20% trans-fats at consumption rate of 7.5% of daily calories, replacement with butter would decrease risk by 2.7% and replacement with canola oil would reduce risk by 9.9%. From the cohort analysis, butter would have little net effect (0.5% increased risk) while soybean and canola oil would have the largest reduction in risk (19.0 and 21.8%, respectively).
A 2009 meta-analysis of cohort studies and randomized controlled trials from the University of Otago, New Zealand, found that the results of the cohort studies showed no association between coronary heart disease mortality nor total coronary heart disease events when saturated fat was increased in place of carbohydrates. In the randomized controlled trials where the ratio of polyunsaturated fat to saturated fat had been increased, the risk of coronary heart disease fatality was not changed, but the risk of total coronary heart disease events was decreased. The analysis was critical of the limitations of the primary evidence available, considering the evidence from cohort studies to be mostly unreliable.
A 2009 pooled analysis of 11 cohort studies supported by the National Heart, Lung, and Blood Institute, National Institutes of Health, the Danish Heart Foundation and the Danish Medical Research Council found that substituting polyunsaturated fatty acids in place of saturated fatty acids at a rate of 5% of energy intake led to 13% decrease in coronary events and a 26% decrease in coronary deaths.
A 2003 meta-analysis of prevention dietetic studies found the benefit of a modified fat diet in primary prevention is potentially significant if it is maintained for a sufficient length of time.
A 1999 review found that substitution of the fat from one ounce of nuts for equivalent energy from saturated fat was associated with a 45% reduction in risk of coronary heart disease.
A 1994 meta-analysis from the University of Sydney of the effect on coronary events and total mortality in dietary intervention trials found a 6% reduction in mortality and 13% reduction in events. The dietary advice differed between the trials reviewed, but most prescribed a reduced saturated fat and cholesterol intake with partial replacement by polyunsaturated oils. The review noted that a large controlled trial "may no longer be ethical."
Some meta-analyses have found a significant relationship between saturated fat and serum cholesterol levels, and serum cholesterol levels and cardiovascular disease. However, the ratio of total to high density lipoprotein cholesterol is considered a better indicator and some saturated fats (lauric acid and stearic acid) improve the ratio.
The 2009 European Society of Cardiology Textbook of Cardiovascular Medicine states that in cohort studies the positive relationship between fat intake and CVDs was linked to their saturated fatty acid content.
2007's Cardiovascular Prevention and Rehabilitation states that large epidemiological studies have shown consistent associations between the intake of saturated fatty acids and CHD mortality.
According to the 2007 Critical Pathways in Cardiovascular Medicine, substituting unsaturated fat for saturated fat may lower LDL cholesterol without simultaneously lowering HDL cholesterol. This dietary principle partly underlies the Mediterranean style of diet, which has been associated with reduced cardiovascular event rates in two randomized controlled trials.
The 2003 second edition of Evidence-based Cardiology in 'PartII: Prevention of cardiovascular diseases' recommends a low intake of SFA, less than 7% of daily calories, and intake of foods rich in myristic and palmitic acids should be especially reduced. The recommendation was evaluated to be supported by the best grade of available evidence.
Position statements and guidelines of major health organizations
In 2003 a World Health Organization (WHO) and Food and Agricultural Organization (FAO) expert consultation report concluded that "intake of saturated fatty acids is directly related to cardiovascular risk. The traditional target is to restrict the intake of saturated fatty acids to less than 10%, of daily energy intake and less than 7% for high-risk groups. If populations are consuming less than 10%, they should not increase that level of intake. Within these limits, intake of foods rich in myristic and palmitic acids should be replaced by fats with a lower content of these particular fatty acids. In developing countries, however, where energy intake for some population groups may be inadequate, energy expenditure is high and body fat stores are low (BMI <18.5 kg/m2). The amount and quality of fat supply has to be considered keeping in mind the need to meet energy requirements. Specific sources of saturated fat, such as coconut and palm oil, provide low-cost energy and may be an important source of energy for the poor."
In its 2007 guidelines, the European Society of Cardiology states that there are strong, consistent, and graded relationships between saturated fat intake, blood cholesterol levels, and the mass occurrence of cardiovascular disease. The relationships are accepted as causal.
The Mayo Clinic considers saturated fats potentially harmful and monounsaturated and polyunsaturated fats potentially helpful. It references the Dietary Guidelines for Americans, 2010 and recommends reducing foods rich in saturated fat and emphasizing options with more monounsaturated and polyunsaturated fats.
The 2007 position statement of the American Dietetic Association and the Dieticians of Canada holds that epidemiological studies have shown a positive association between the intake of saturated fatty acid and the incidence of coronary heart disease.
Consumption of saturated fat is a risk factor for cardiovascular disease in the view of the Canadian Heart and Stroke Foundation, the American Heart Association, the British Heart Foundation, the National Heart Foundation of Australia, the National Heart Foundation of New Zealand  and the World Heart Federation. The Irish Heart Foundation states that saturated fats can raise your LDL cholesterol and increase your chances of getting heart disease.
The Dietary Guidelines for Americans, 2010 produced by the U.S. Department of Agriculture (USDA) and U.S. Department of Health and Human Services says the human body makes more than enough saturated fats to meet its needs and does not require more from dietary sources. It says higher levels of saturated fats are associated with higher levels of total cholesterol and low-density lipoprotein "bad" cholesterol and recommends reduced saturated fat intake. The guidelines are based on the recommendations of the Dietary Guidelines Advisory Committee (DGAC) report that incorporated the results of the review of 12 studies from 2004 to 2009 conducted by the Nutrition Evidence Library (NEL) part of the Evidence Analysis Library Division of the USDA's Center for Nutrition Policy and Promotion. The NEL concluded that there was "strong" evidence that dietary saturated fats increased serum total cholesterol and LDL cholesterol and increased risk of cardiovascular disease.
Editorial, commentary and conference findings in medical journals
A May 2011 extended feature in the Journal of the American Dietetic Association published an edited summary of a debate at the American Dietetic Association's 93rd conference. Regarding saturated fat, the key point agreed upon by the panel and scientific community at large was that "Researchers agree that replacing saturated fat with healthy PUFAs is beneficial for health and [cardiovascular disease]." Recommendations for dieticians emphasized using mono- and poly-unsaturated fats whenever possible, avoiding trans fats, that while "The evidence against saturated fat may not be as strong as dietary guidelines have interpreted [it is clear] that PUFAs (especially) and MUFAs are healthy fats", and that while there is room for saturated fats within the diet but "[they] should not be viewed as good for you".
It also noted "dietary patterns are more important than single dietary components" and recommended dietitians "to talk food, not chemicals".
A 2010 perspective in the American Journal of Clinical Nutrition found that the risk of coronary heart disease (CHD) is reduced when saturated fatty acids are replaced with polyunsaturated fatty acids but no clear benefit in replacing saturated fatty acids with carbohydrates or monounsaturated fatty acids.
In an October 2010 article in the journal Nutrition, the 2010 Dietary Guidelines Advisory Committee (DGAC) report was criticized for the "use of an incomplete body of relevant science; inaccurately representing, interpreting, or summarizing the literature; and drawing conclusions and/or making recommendations that do not reflect the limitations or controversies in the science" stating rather that the evidence associating dietary SFA with increased risk of CVD is inconclusive.
A response by Jeremiah Stamler to the 2010 meta-analysis by Siri-Tarino et al. was point-by-point critical of the analysis, stating "The authors are inaccurate in concluding that 'there are few epidemiologic or clinical trial data to support a benefit of replacing saturated fat with carbohydrate.'" and questioned if it was the intent to dissociate themselves from prevailing recommendations, "A vast array of concordant multidisiplinary research evidence is the sound foundation for these recommendations."
A 2009 review from the University of São Paulo found that the best evidence showed reduced intake of saturated fat decreased risk for coronary heart disease.
A 2009 review from King's College London found that epidemiological evidence suggested a negative influence on vascular function from saturated fat, but that the experimental evidence did not support this convincingly.
A 2009 scientific conference hosted by the University of Reading (UK) and organized and facilitated by the International Dairy Federation’s Standing Committee on Nutrition and Health found that despite the contribution of dairy products to the saturated fatty acid intake of the diet, there was no clear evidence that dairy food consumption is consistently associated with a higher risk of CVD.
A 2004 commentary from the Nestle Research Center stated that no randomized clinical trials of low-fat diets or low-saturated fat diets of sufficient duration had been carried out. The influence of varying saturated fatty acid intakes against a background of different individual lifestyles and genetic backgrounds were recommended as the focus in future studies. Saturated fat intakes may be monitored more closely than were total fat intakes, therefore ignoring the possibility that simply a larger fat intake may lead to a higher risk of coronary diseases. It also suggests that other parameters may be overlooked, such as carbohydrates intakes.
A 2000 consensus statement appearing in The American Journal of Medicine listed in factors important to prevent heart disease a substantial reduction of saturated fat and partially hydrogenated oils, and the substitution of saturated fats by unsaturated fats.
Gary Taubes, a science writer and three-time winner of the Science in Society Award of the National Association of Science Writers, has stated, "Dietary fat, whether saturated or not, is not a cause of obesity, heart disease, or any other chronic disease of civilization."
Author and journalist Michael Pollan, a two-time James Beard Foundation Award winner, in his book In Defense of Food – An Eater's Manifesto states "The amount of saturated fat in the diet probably may have little if any bearing on the risk of heart disease, and evidence that increasing polyunsaturated fats in the diet will reduce risk is slim to nil."
Mary G. Enig, a nutritionist who is a member of the International Network of Cholesterol Skeptics states "there is very little evidence to support the contention that a diet low in cholesterol and saturated fat actually reduces death from heart disease."
The Dairy Farmers of Canada quote Andrew Mente, PhD (Assistant Professor, Department of Clinical Epidemiology and Biostatistics, McMaster University) that "In light of new scientific data, it appears that saturated fat is not associated with an increased risk of cardiovascular disease."
- Diet and heart disease
- Fast food
- French paradox
- Healthy diet
- Junk food
- Lipid hypothesis
- Medical research related to low-carbohydrate diets
- Ffion Lloyd-Williams; Martin O’Flaherty; Modi Mwatsama; et al. (July 2008). "Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats". Bulletin of the World Health Organization 86 (7): 497–576. Retrieved 2011-01-25.
- Ravnskov, Uffe. (October 1, 2000). The Cholesterol Myths – Exposing the Fallacy that Saturated Fat and Cholesterol Cause Heart Disease. Newtrends. ISBN 978-0-9670897-0-6.
- Steinberg, Daniel. (September 24, 2007). The Cholesterol Wars – The Skeptics vs. the Preponderance of Evidence. Academic Press. ISBN 978-0-12-373979-7.
- Yamagishi, Kazumasa; et al. (August 2010). "Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study". The American Journal of Clinical Nutrition 92 (4): 759–765. Retrieved 2015-09-12.
- Siri-Tarino PW, Sun Q, Hu FB, Krauss RM; Sun; Hu; Krauss (March 2010). "Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease". The American Journal of Clinical Nutrition 91 (3): 535–46. doi:10.3945/ajcn.2009.27725. PMC 2824152. PMID 20071648.
- Joint WHO/FAO Expert Consultation (2003). Diet, Nutrition and the Prevention of Chronic Diseases (WHO technical report series 916) (PDF). World Health Organization. pp. 81–94. ISBN 92-4-120916-X. Retrieved 2011-03-11.
- Kris-Etherton, PM; Innis, S; American Dietetic, Association; Dietitians Of, Canada (September 2007). "Position of the American Dietetic Association and Dietitians of Canada: Dietary Fatty Acids" (PDF). Journal of the American Dietetic Association 107 (9): 1599–1611 . doi:10.1016/j.jada.2007.07.024. PMID 17936958. Retrieved 2011-03-18.
- "Food Fact Sheet - Cholesterol" (PDF). British Dietetic Association. Retrieved 3 May 2012.[dead link]
- "Frequently Asked Questions about Fats". American Heart Association. Retrieved 3 May 2012.
- "Fats explained". Retrieved 2012-05-03.
- "Cardiovascular Disease Risk Factors". Retrieved 2012-05-03. Cite error: Invalid
<ref>tag; name "WorldHeartFederation" defined multiple times with different content (see the help page).
- "Eat less saturated fat". National Health Service. Retrieved 2012-05-03.
- "Nutrition Facts at a Glance - Nutrients: Saturated Fat". Food and Drug Administration. 2009-12-22. Retrieved 2012-05-03.[dead link]
- "Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol". European Food Safety Authority. Retrieved 3 May 2012.
- Steinberg, D. (2004). "Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: Part I". The Journal of Lipid Research 45 (9): 1583. doi:10.1194/jlr.R400003-JLR200.
- Blackburn, H. (2012). "20th-Century "Medical Marco Polos" in the Origins of Preventive Cardiology and Cardiovascular Disease Epidemiology". The American Journal of Cardiology 109 (5): 756. doi:10.1016/j.amjcard.2011.10.038.
- de Langen, Cornelis (1916). "Cholesterine-stofwisseling en rassenpathologie". Geneeskundig Tijdschrift voor Nederlansch-Indie (in Dutch) 56: 1–34.
- Teicholz, Nina (6 May 2014). "The Questionable Link Between Saturated Fat and Heart Disease". Wall Street Journal. Retrieved 9 May 2015.
- Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JT, Simonson E (1 September 1963). "Coronary heart disease among Minnesota business and professional men followed 15 years". Circulation 28 (3): 381–95. doi:10.1161/01.cir.28.3.381. PMID 14059458.
- Famous Polemics on Diet-Heart Theory. Henry Blackburn, School of Public Health, University of Minnesota. http://www.epi.umn.edu/cvdepi/essay.asp?id=33 accessed 18th March 2014
- Keys, Ancel (1980). Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press. ISBN 0-674-80237-3.
- de Souza, Russell J; Mente, Andrew; Maroleanu, Adriana; Cozma, Adrian I; Ha, Vanessa; Kishibe, Teruko; Uleryk, Elizabeth; Budylowski, Patrick; Schünemann, Holger; Beyene, Joseph; Anand, Sonia S (11 August 2015). "Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies". BMJ 351: h3978. doi:10.1136/bmj.h3978. PMID 26268692.
- Schwab, Ursula; Lauritzen, Lotte; Tholstrup, Tine; Haldorssoni, Thorhallur; Riserus, Ulf; Uusitupa, Matti; Becker, Wulf (10 July 2014). "Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review". Food & Nutrition Research 58. doi:10.3402/fnr.v58.25145. PMID 25045347.
- Chowdhury, Rajiv; et al. (March 18, 2014). "Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis". Ann Intern Med.
- Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore H, Smith GD; Summerbell; Thompson; Sills; Roberts; Moore; Davey Smith (July 2011). "Reduced or modified dietary fat for preventing cardiovascular disease". The Cochrane Library (7): CD002137. doi:10.1002/14651858.CD002137.pub2. PMC 4163969. PMID 21735388.
- Mozaffarian D, Micha R, Wallace S; Micha; Wallace (March 2010). Katan, Martijn B., ed. "Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". PLoS Medicine 7 (3): 1–10. doi:10.1371/journal.pmed.1000252. ISSN 1549-1277. PMC 2843598. PMID 20351774.
- Danaei G; et al. (April 2009). Hales, Simon, ed. "The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors". PLoS Medicine 6 (4): e1000058. doi:10.1371/journal.pmed.1000058. ISSN 1549-1277. PMC 2667673. PMID 19399161. Retrieved 2011-03-24.
- Mente A, de Koning L, Shannon HS, Anand SS; De Koning; Shannon; Anand (April 2009). "A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease". Arch. Intern. Med. 169 (7): 659–69. doi:10.1001/archinternmed.2009.38. PMID 19364995. Free full-text
- Skeaff, Murray; Miller, Jody (15 September 2009). "Dietary fat and coronary heart disease: Summary of evidence from prospective cohort and randomised controlled trials" (PDF). Annals of nutrition & metabolism 55 (1–3): 173–U287. doi:10.1159/000229002. ISSN 0250-6807. PMID 19752542. Retrieved 2011-03-12.
- Jakobsen, MU; O'Reilly, EJ; Heitmann, BL; Pereira, MA; Bälter, K; Fraser, GE; Goldbourt, U; Hallmans, G; Knekt, P; et al. (2009). "Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies". The American journal of clinical nutrition 89 (5): 1425–32. doi:10.3945/ajcn.2008.27124. PMC 2676998. PMID 19211817.
- Van Horn L; et al. (February 2008). "The evidence for dietary prevention and treatment of cardiovascular disease". Journal of the American Dietetic Association 108 (2): 287–331. doi:10.1016/j.jada.2007.10.050. ISSN 0002-8223. PMID 18237578.
- Chanu B (September 2003). "Primary dietetic prevention of ischaemic heart disease". Archives des Maladies du Coeur et des Vaisseux 96 (Sp. Iss. 6): 21–25. ISSN 0003-9683.
- Hu FB, Stampfer MJ; Stampfer (November 1999). "Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence". Current Atherosclerosis Reports 1 (3): 204–209. doi:10.1007/s11883-999-0033-7. PMID 11122711.
- Truswell, A. Stewart (February 1994). "Review of dietary intervention studies: effect on coronary events and on total mortality". Australian and New Zealand Journal of Medicine 24 (1): 98–106. doi:10.1111/j.1445-5994.1994.tb04444.x. PMID 8002875.
- "Dietary fat and heart disease study is seriously misleading". March 19, 2014.
- kummerow, Fred (2013). "Interaction between sphingomyelin and oxysterols contributes to atherosclerosis and sudden death". Am J Cardiovasc Dis 3 (1): 17–26. PMC 3584645. PMID 23459228.
- Siri-Tarino PW, Sun Q, Hu FB, Krauss RM; Sun; Hu; Krauss (March 2010). "Saturated fat, carbohydrate, and cardiovascular disease". The American Journal of Clinical Nutrition 91 (3): 502–9. doi:10.3945/ajcn.2008.26285. PMC 2824150. PMID 20089734.
- Scarborough P, Rayner M, van Dis I, Norum K; Rayner; Van Dis; Norum (August 2010). "Meta-analysis of effect of saturated fat intake on cardiovascular disease: overadjustment obscures true associations". The American Journal of Clinical Nutrition 92 (2): 458–459. doi:10.3945/ajcn.2010.29504. PMID 20534750.
- Mozaffarian, D; Clarke, R (May 2009). "Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils" (PDF). European Journal of Clinical Nutrition 63: S22–S33. doi:10.1038/sj.ejcn.1602976. PMID 19424216. Retrieved 2011-03-22.
- Clarke, R; Frost, C; Collins, R; Appleby, P; Peto, R (1997). "Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies". BMJ (Clinical research ed.) 314 (7074): 112–7. doi:10.1136/bmj.314.7074.112. PMC 2125600. PMID 9006469.
- Mensink RP, Zock PL, Kester ADM, Katan MB; Zock; Kester; Katan (May 2003). "Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials". American Journal of Clinical Nutrition 77 (5): 1146–1155. ISSN 0002-9165. PMID 12716665.
- Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R; Lewington; Whitlock; Clarke; Sherliker; Emberson; Halsey; Qizilbash; Peto; Collins (December 2007). "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths". Lancet 370 (9602): 1829–39. doi:10.1016/S0140-6736(07)61778-4. PMID 18061058.
- Camm, John; Luscher, Thomas; Serruys, Patrick (2009). The European Society of Cardiology Textbook of Cardiovascular Medicine. Blackwell Publishing. p. 257. ISBN 978-0-19-957285-4.
- Perk, J; et al. (2007). Cardiovascular Prevention and Rehabilitation. Springer-Verlag London Limited. p. 184. ISBN 978-1-84628-462-5.
- Cannon, Christopher; O'Gara, Patrick (2007). Critical Pathways in Cardiovascular Medicine, 2nd Edition. Lippincott Williams & Wilkins. p. 243.
- Yusuf, S; et al. (2003). Evidence-based Cardiology, Second edition. BMJ Books. p. 320. ISBN 0-7279-1699-8.
- Joint WHO/FAO Expert Consultation (2003). Diet, Nutrition and the Prevention of Chronic Diseases (WHO technical report series 916) (PDF). World Health Organization. pp. 81–94. ISBN 92-4-120916-X. Retrieved 2011-03-11.
- European Society of Cardiology; Atar; Borch-Johnsen; Boysen; Burell; Cifkova; Dallongeville; De Backer; Ebrahim; Gjelsvik; Herrmann-Lingen; Hoes; Humphries; Knapton; Perk; Priori; Pyorala; Reiner; Ruilope; Sans-Menendez; Scholte Op Reimer; Weissberg; Wood; Yarnell; Zamorano; Walma; Fitzgerald; Cooney; Dudina; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG) (2007). "European guidelines on cardiovascular disease prevention in clinical practice: executive summary" (PDF). European Heart Journal 28 (19): 2375–2414. doi:10.1093/eurheartj/ehm316. PMID 17726041.
- Dietary fats: Know which types to choose Mayo Clinic website
- Mead, A; et al. (December 2006). "Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease – evidence from systematic reviews of randomized controlled trials (second update, January 2006)". Journal of Human Nutrition and Dietetics 19 (6): 401–419. doi:10.1111/j.1365-277X.2006.00726.x. PMID 17105538.
- "Dietary fats, oils and cholesterol". Retrieved 2010-12-22.
- American Heart Association. "Fat". Retrieved 2011-03-12.[dead link]
- "'Reduce saturated fat' urges Heart Foundation after major review" (PDF). Retrieved 2014-12-24.
- Seddon MB. ChB. MPH., M (March 1999). "Dietary Fats: An Evidence-Based Nutrition Statement from the National Heart Foundation of New Zealand's Nutrition Advisory Committee" (PDF). Retrieved 2010-12-22.[dead link]
- "Cholesterol". Irish Heart Foundation. Retrieved 2014-07-08.
- U.S. Department of Agriculture and U.S. Department of Health and Human Services. (December 2010). Dietary Guidelines for Americans, 2010 (7th Edition). Washington, DC: U.S. Government Printing Office.
- USDA Nutrition Evidence Library. (2010). What is the effect of saturated fat intake on increased risk of cardiovascular disease or type 2 diabetes?. Retrieved March 13, 2011.
- Dietary Guidelines Advisory Committee. (June 14, 2010). Part D. Section 3: Fatty Acids and Cholesterol. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans.
- Zelman, K. (2011). "The Great Fat Debate: A Closer Look at the Controversy—Questioning the Validity of Age-Old Dietary Guidance". Journal of the American Dietetic Association 111 (5): 655–658. doi:10.1016/j.jada.2011.03.026. PMID 21515106.
- Astrup, A; Dyerberg, J.; Elwood, P.; Hermansen, K.; Hu, F. B.; Jakobsen, M. U.; Kok, F. J.; Krauss, R. M.; Lecerf, J. M.; et al. (January 2011). "The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?". American Journal of Clinical Nutrition 93 (4): 684–688. doi:10.3945/ajcn.110.004622. PMC 3138219. PMID 21270379.
- Hite Adele H.; Richard; Feinman David; Guzman Gabriel E.; et al. (October 2010). "In the face of contradictory evidence: Report of the Dietary Guidelines for Americans Committee". Nutrition 26 (10): 915–924. doi:10.1016/j.nut.2010.08.012. PMID 20888548.
- Stamler J. (February 2010). "Diet-heart: a problematic revisit" (PDF). The American Journal of Clinical Nutrition 91 (3): 497–99. doi:10.3945/ajcn.2010.29216. PMID 20130097.
- Lottenberg AMP (July 2009). "Importance of the dietary fat on the prevention and control of metabolic disturbances and cardiovascular disease". Arquivos Brasileiros de Endocrinologia e Metabologia 53 (5): 595–607. doi:10.1590/S0004-27302009000500012. ISSN 0004-2730. PMID 19768250.
- Hall WL (June 2009). "Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function". Nutrition Research Reviews 22 (1): 18–38. doi:10.1017/S095442240925846X. PMID 19243668.
- German JB; Gibson RA; Krauss RM; et al. (June 2009). "A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk". European Journal of Nutrition 48 (4): 191–203. doi:10.1007/s00394-009-0002-5. PMC 2695872. PMID 19259609.
- German JB, Dillard CJ; Dillard (September 2004). "Saturated fats: what dietary intake?". The American Journal of Clinical Nutrition 80 (3): 550–9. PMID 15321792.
- Knopp RH, Retzlaff BM; Retzlaff (November 2004). "Saturated fat prevents coronary artery disease? An American paradox". The American Journal of Clinical Nutrition 80 (5): 1102–3. PMID 15531654.
- Assmann G; et al. (December 30, 2002). "Dietary Fat Consensus Statements". American Journal of Medicine 113 (9): 5–8. doi:10.1016/S0002-9343(02)01474-2. PMID 12566132.
- Taubes, Gary (2007). Good Calories, Bad Calories. Knopf. p. 454. ISBN 978-1-4000-3346-1. Retrieved 2011-01-02.
- Taubes, Gary. (July 7, 2002). What if It's All Been a Big Fat Lie?. The New York Times Magazine. Retrieved March 13, 2011.
- Pollan, Michael. (2008). In Defense of Food – An Eater's Manifesto. Penguin. p. 43. ISBN 1-59420-145-5.
- Fallon, Sally and Mary Enig. (1999). The Truth About Saturated Fats. Nourishing Traditions – The Cookbook that Challenges Politically Correct Nutrition and the Diet Dictocrats. NewTrends. ISBN 0-9670897-3-5.
- Enig, Mary and Sally Fallon. (2006). Eat Fat, Lose Fat – The Healthy Alternative to Trans Fats. Plume. ISBN 978-0-452-28566-8.
- "New evidence reveals that saturated fat does not increase the risk of cardiovascular disease". Retrieved 2011-03-18.